The Alberta NutrIMM Study - Nutrition and Immunity
-
- STATUS
- Recruiting
-
- participants needed
- 132
-
- sponsor
- University of Alberta
Summary
Excess weight, nutrition, and blood sugar levels can all affect immune function, which in turn can affect participants risk for heart disease and type 2 diabetes (T2DM). It is not known how diet, blood sugar, and weight affect immune function.
The purpose of the study is to look at how weight, diet and high blood sugar levels affect immune function. Results of the study will be compared to results of the control group (which will go through the same activities as the experimental groups).
Description
Rationale: Obesity is associated with several risk factors (for example, high blood sugar, poor insulin response and inflammation) that increase risk of developing cardiovascular disease and type 2 diabetes (T2DM). Obesity is also associated with abnormalities in the immune system and an increased risk of infection. Specific components of the diet such, as high dietary intake of fat and sugar, influence not only the development of obesity but also the immune system. It is unknown if the immune abnormalities associated with obesity in humans are due to: 1) excess body fat and/or 2) elevated blood sugar levels, often seen in obesity and/or 3) overall diet quality of an individual (for example high fat and/or high sugar intakes).
Research aims: The overall aim of this research proposal is to determine if diet or alterations in blood sugar levels independently affect inflammation and immune function in obese subjects. To achieve this goal, three objectives will be pursued: 1) to determine how obesity affects inflammation and immune function; 2) to determine how alterations in blood sugar levels affect inflammation and immune function; 3) to identify specific dietary factors that affect changes in immune function that are related to obesity.
Methodology: The study will recruit 4 groups of subjects that are similar in age and sex: lean subjects with normal blood sugar levels (NG); obese subjects with normal blood sugar levels (obese-NG); obese subjects who are pre-diabetic (as defined by having high blood sugar levels - but not high enough to be defined as having diabetes; GI); obese subjects who have type 2 diabetes (obese-T2DM).
Participants will consume a typical North American/Canadian diet that will maintain their weight for a 4-week time period (all food will be provided for the subjects by the Human Nutrition Clinical Research Unit at the University of Alberta). Immune system markers (inflammation in the blood and the response of immune cells) and cardiovascular disease markers (blood sugar and insulin) will be compared among the 4 groups of participants before and at the end of the study.
A stool sample will also be collected before and after the diet intervention to look at the effects of weight and blood sugar levels on the type of bacteria in the participants gut as part of a Stool Sub-study. Research has shown that weight and blood sugar levels may affect the type of bacteria in the participants gut, which in turn can affect immune function and health risk. This is not a part of the main study, and the participants stool sample will be analyzed in future research.
Outcomes: By comparing these four groups, the investigators will be able to gain an understanding of the immune complications associated with obesity alone (ie excess body fat) and the relationship between blood sugar levels and diet with immune complications. Thus, this study will identify dietary interventions to counteract the immune abnormalities associated with obesity, which may in turn have implications for affecting the risk of cardiovascular disease and T2DM associated with obesity.
Details
| Condition | NIDDM, Obesity, Obesity |
|---|---|
| Age | 18-65 years |
| Treatment | North American Diet |
| Clinical Study Identifier | NCT04291391 |
| Sponsor | University of Alberta |
| Last Modified on | 19 February 2024 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Add a private note
- Select a piece of text from the left.
- Add notes visible only to you.
- Send it to people through a passcode protected link.
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.